Experts Flag Potential Safety Concerns in New Prader-Willi Drug

Source Summary

Prader-Willi syndrome experts are warning of potential safety risks associated with extended-release diazoxide choline (Vykat XR), a drug approved last year for treating extreme hunger in patients with the condition.